An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

January 31, 2003

Conditions
Bipolar Disorder
Interventions
DRUG

Divalproex Sodium (Depakote ER)

Trial Locations (18)

10016

NYU School of Medicine - Bellevue, New York

11423

The Holliswood Hospital, Holliswood

20010

Washington Hospital Center, Washington D.C.

20850

Centers for Behavioral Health, LLC, Rockville

22041

CNS of Northern Virginia, Falls Church

39216

University of Mississippi Medical Center, Jackson

40202

University of Louisville Bipolar Research Program, Louisville

44109

MetroHealth Medical Center, Cleveland

48047

Pioneer Research, Baltimore

53295

VAMC, Milwaukee

60194

Mark Lerman, MD, Hoffman Estates

71101

Brentwood Research Inst., Shreveport

77030

UT Mental Sciences Institute, Houston

78223

San Antonio State Hospital, San Antonio

90505

AVI Clinical Research, Torrance

90703

Comprehensive Neuroscience of SCA, Cerritos

02478

McLean Hospital, Belmont

08021

Steven A. Glass, MD, Clementon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY